Submit Article
Back to Journal

SM Journal of Neurological Disorders and Stroke

Efficacy and Cost of Atypical Antipsychotics in Treatment and Management of Dementia

[ ISSN : 3067-9982 ]

Abstract
Details

Received: 11-Nov-2015

Accepted: 12-Nov-2015

Published: 10-Dec-2015

Review Article | Volume 1 - Issue 1 | Article DOI :

Download PDF

Oranuch Thongchundee, Anil Gumber*, Khaled Khatab, and Leher Gumber

Centre for Health and Social Care Research, Sheffield Hallam University, UK

Corresponding Author:

Anil Gumber, Centre for Health and Social Care Research, Sheffield Hallam University, UK.

Keywords

Dementia; Antipsychotics; Parkinson’s disease

Abstract

The current population is living longer than ever before as a result of improved health care services; therefore, the size of the ageing population is increasing [1]. Dementia is emerging as one of the main conditions affecting the elderly population. According to the WHO report, in 2010, there were approximately 35.6 million people suffering from dementia worldwide. This figure continues to rise, doubling approximately every 20 years and it is estimated that this will soon rise to 65.7 million by 2030, and further to 115.4 million by 2050. Current incidence shows an individual is diagnosed with dementia every four seconds. This has substantial socioeconomic and financial implications on people globally and the societal costs associated with disease were estimated at US$ 605 billion in 2010 [2].

Citation

Thongchundee O, Gumber A, Khatab K and Gumber L. Efficacy and Cost of Atypical OPEN Antipsychotics in Treatment and Management of Dementia. SM J Neurol Disord Stroke. 2015; 1(1): 1002.